Heat Biologics Secures New Financing Round

  • Feed Type
  • Date
    12/13/2012
  • Company Name
    Heat Biologics
  • Mailing Address
    100 Europa Drive Chapel Hill, NC 27517 USA
  • Company Description
    Heat Biologics (Heat) is a clinical-stage company focused on the development and commercialization of its HS-System, a platform technology that offers a novel approach to treating cancer and other diseases by using live, modified cell lines to activate the immune system against specific defined targets.
  • Website
    http://www.heatbio.com
  • Transaction Type
    Debt
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds of the credit facility will be used to support ongoing clinical trials and company growth.
  • M&A Terms
  • Venture Investor